Clean Cells acquires Karyologic to accelerate expansion in US biologics market

Montaigu-Vendée, near Nantes, France, April 8, 2025 – Clean Cells, part of the Clean Biologics group, a leading biopharmaceutical quality control services provider specializing in biologics GMP testing, today announces the strategic acquisition of Karyologic Inc., a specialized karyotyping services company based in Durham, North Carolina, USA. This strategic acquisition marks a key milestone in Clean Cells’ international growth: establishing an operational presence in the US.

Karyologic has established itself as a trusted provider of the cytogenetic testing services crucial for biologics development, as well as cell therapy products. This acquisition enables Clean Cells to immediately offer enhanced karyotype services to its North American clients, while setting the foundation to bring its comprehensive services offer closer to its US-based customers. 

“This acquisition marks an exciting new chapter for Clean Cells as we strengthen our operational footprint in the US. Our ambition is clear: to support our clients’ innovation in biologics with exceptional service capabilities both in Europe and North America,” said Joseph Jammal, CEO of Clean Cells. 

“Joining Clean Cells allows us to combine our expertise in cytogenetic analysis with their broad biologics service portfolio. This union ensures we deliver even greater value and reliability to our clients as part of a globally recognized organization,” added Elizabeth Gonzalez, CEO of Karyologic. 

“We are enthusiastic about this strategic alignment,” said Denis Ribon, managing partner at ARCHIMED, Clean Cells’ majority investor. “This acquisition aligns perfectly with our commitment to growing Clean Cells’ international presence and strengthening its position in the rapidly evolving biologics sector.”

The acquisition officially closed on March 31, 2025, setting in motion the immediate integration activities designed to leverage complementary strengths and enhance service delivery.

About Karyologic

Karyologic specializes in karyotype analysis, providing essential cytogenetic testing services to the biologics sector. Its expertise helps clients ensure genetic stability and regulatory compliance throughout the development of biotherapeutics.

www.karyologic.com

About ARCHIMED

With offices in Europe, North America and Asia, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and a financial partner to healthcare businesses. Prioritized areas of focus include Animal & Environmental Health, Biopharma Products, Consumer Health, Diagnostics, Healthcare IT, Life Science Tools & Biologic Services, MedTech and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services. ARCHIMED manages €8 billion across its various funds. Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.

www.archimed.group

About Clean Cells

Clean Cells is a subsidiary of Clean Biologics. It offers (i) quality control and biological safety tests for biopharmaceutical products to assist in regulatory compliance, (ii) production of cell banks and GMP-grade BSL2/BSL3 virus seed stock, (iii) supply of secure storage for these products and (iv) development and validation of bespoke analysis tools.

The company was created in 2000, when three biologists from the Aventis–Institut de France Foundation sought to offer innocuity testing for biopharmaceuticals. Clean Cells is now one of the largest European companies within this sector. Its strong customer focus and sizable product catalog (which expands annually) have made it a key player in the development of novel treatments and in personalized medicine. Clean Cells also stands out for its ability to react and adapt to its customers’ needs and the transparency of its production and quality control processes.

Based near Nantes, in Western France, Clean Cells employs 130 staff. 

www.clean-cells.com